Acamprosate and alcohol: III. Effects on alcohol discrimination in the rat

European Journal of Pharmacology

Volumn 305, Issue 1-3, 1996, Pages 51-56

  Spanagel, Rainer ^a   Zieglgänsberger, Walter ^a   Hundt, Wolfgang ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

acamprosate; drug discrimination; ethanol; NMDA receptor antagonist; rat

Indexed keywords

ACAMPROSATE; ALCOHOL; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG ANTAGONISM; DRUG DISCRIMINATION; DRUG MECHANISM; INSTRUMENTAL CONDITIONING; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; STIMULUS GENERALIZATION;

EID: 17044458222     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00176-8     Document Type: Article

References (27)

1. Boismare, F., M. Daoust, N. Moore, C. Saligaut, J.-P. Lhuintre, P. Chretien and J. Durlach, 1984, A homotaurine derivate reduced the voluntary intake of ethanol by rats: Are cerebral GABA receptors involved?, Pharmacol. Biochem. Behav. 21, 787.
2. Chabenat, C., P. Chretien, M. Daoust, N. Moore, D. Andre, J.-P. Lhuintre, C. Saligaut, P. Boucly and F. Boismare, 1988, Physico-chemical, pharmacological and pharmacokinetic study of a new GABAergic compound, calcium acetyl homotaurinate, Meth. Fund. Exp. Clin. Pharmacol. 10, 311.
3. Daoust, M., E. Legrand, M. Gewiss, C. Heidebreder, P. DeWitte, G. Tran and P. Durbin, 1992, Acamprosate modulates synaptosomal GABA transmission in chronically alcoholised rats, Pharmacol. Biochem. Behav. 41, 669.
4. Emmett-Oglesby, M.W., D.G. Spencer, Jr. and D.E. Arnoult, 1982, A TRS-80-based for the control of behavioral experiments, Pharmacol. Biochem. Behav. 17, 583.
5. Gewiss, M., C. Heidebreder, L. Opsomer, Ph. Durbin and Ph. DeWitte, 1991, Acamprosate and diazepam differentially modulate alcohol-induced behavioural and cortical alterations in rats following chronic inhalation of ethanol vapour, Alcohol Alcoholism 26, 129.
6. Grant, K.A. and W.L. Woolverton, 1989, Reinforcing and discriminative stimulus effects of Ca-acetyl homotaurine in animals, Pharmacol. Biochem. Behav. 32, 607.
7. Grant, K.A., G. Colombo and B. Tabakoff, 1991a, Competitive and noncompetitive antagonists of the NMDA receptor complex have ethanol-like discriminative stimulus effects in rats, Alcohol. Clin. Exp. Res. 15, 321.
8. Grant, K.A., J.S. Knisely, B. Tabakoff, J.E. Barrett and R.L. Balster, 1991b, Ethanol-like discriminative stimulus effects of non-competitive n-methyl-d-aspartate antagonists, Behav. Pharmacol. 2, 87.
9. Hoffman, P.L., C.S. Rabe, F. Moses and B. Tabakoff, 1989, N-Methyl-D-aspartate receptors and ethanol: Inhibition of calcium flux and cyclic GMP production, J. Neurochem. 52, 1937.
10. Hoffman, P.L. and B. Tabakoff, 1994, The role of the NMDA receptor in ethanol withdrawal, in: Toward a Molecular Basis of Alcohol Abuse, eds. D. Janssen, H. Jörnvall, O. Rydberg, L. Terenius and R.B.L. Vallee, (Birkhäuser, Basel) p. 61.
11. Ladewig, D., T. Knecht, P. Leher and A. Fendl, 1993, Acamprosat - ein Stabilisierungsfaktor in der Langzeitentwöhnung von Alkoholabhängigen, Ther. Umschau 50, 182.
12. Le Magnen, J., G. Tran, J. Durlach and C. Martin, 1987, Dose-dependent suppression of the high alcohol intake of chronically intoxicated rats by Ca-Acetyl homotaurinate, Alcohol 4, 97.
13. Lhuintre, J.-P., N.D. Moore, C. Saligaut, F. Boismare, M. Daoust, P. Chretien, G. Tran and B. Hillemand, 1985, Ability of calcium bis acetyl homotaurine, a GABA agonist, to prevent relapse in weaned alcoholics, Lancet 1 (8436), 1014.
14. Lhuintre, J.-P., N.D. Moore, G. Tran, L. Steru, S. Langrenon, M. Daoust, Ph. Parot, Ph. Ladure, C. Libert, F. Boismare and B. Hillemand, 1990, Acamprosate appears to decrease alcohol intake in weaned alcoholics, Alcohol Alcoholism 25, 613.
15. Lovinger, D.M., G. White and F.F. Weight, 1989, Ethanol inhibits NMDA-activated ion current in hippocampal neurons, Science 243, 1721.
16. Moore, N.D. and C. Libert, 1991, Acamprosate, citalopram, and alcoholism, Lancet 337, 1228.
17. Putzke, J., R. Spanagel, T.R. Tölle and W. Zieglgänsberger, 1995, Acamprosate differentially alters PTZ-, ethanol withdrawal- and PTZ plus ethanol withdrawal-induced c-fos expression in rat brain, Alcohol Alcoholism 30, 550
18. Sanger, D.J., 1993, Substitution by NMDA receptor antagonists and other drugs in rats trained to discriminate ethanol, Behav. Pharmacol. 4, 523.
19. Sass, H., M. Soyka, K. Mann and W. Zieglgänsberger, 1996, Relapse prevention by acamprosate: results from a placebo controlled study in alcohol dependence, Arch. Gen. Psychiatry (in press).
20. Schechter, M.D., S.M. Meehan, T.L. Gordon and D.M. McBurney, 1993, The NMDA receptor antagonist dizocilpine produces ethanol-like discrimination in the rat, Alcohol 10, 197.
21. Shelton, K.L. and R.L. Balster, 1994, Ethanol drug discrimination in rats: substitution with GABA agonists and NMDA receptor antagonist, Behav. Pharmacol. 5, 441.
22. Spanagel, R., S.M. Hölter, K. Allingham and W. Zieglgänsberger, 1995a, Acamprosate and reinstatement behaviour in the alcohol-dependent rat, Alcohol Alcoholism 30, 551
23. Spanagel, R., J. Putzke, W. Zieglgänsberger and B. Schöbitz, 1995b, Effects of acamprosate on alcohol withdrawal, Alcohol Alcoholism 30, 552
24. Spencer, D.G., Jr. and M.W. Emmett-Ogleshy, 1985, Parallel processing strategies in the application of microcomputers to the behavioral laboratory, Behav. Res. Meth. Inst. 17, 294.
25. Tallarida, R.J. and R.B. Murray, 1986, Manual of pharmacological calculation with computer programs, 2nd edn. (Springer, New York).
26. Zeise, M.L., S. Kasparov, M. Capogna and W. Zieglgänsberger, 1993, Acamprosate (calciumacetylhomotaurinate) decreases postsynaptic potentials in the rat neocortex: possible involvement of excitatory amino acid receptors, Eur. J. Pharmacol. 231, 47.
27. Zieglgänsberger, W., C. Hauser, J. Putzke, R. Spanagel and C. Wetzel, 1995, The enhanced excitability of central neurons following chronic alcohol intake is reduced by acamprosate, Pharmacopsychiatry 28, 231.